Free Trial

SkinBioTherapeutics (SBTX) Competitors

SkinBioTherapeutics logo
GBX 22.50 -0.75 (-3.23%)
As of 11:03 AM Eastern

SBTX vs. ARIX, 4BB, CIR, BVXP, HVO, AVCT, TILS, VSN, SCLP, and MPH

Should you be buying SkinBioTherapeutics stock or one of its competitors? The main competitors of SkinBioTherapeutics include Arix Bioscience (ARIX), 4basebio (4BB), Circassia Group (CIR), Bioventix (BVXP), hVIVO (HVO), Avacta Group (AVCT), Tiziana Life Sciences (TILS), Verseon (VSN), Scancell (SCLP), and Mereo BioPharma Group plc (MPH.L) (MPH). These companies are all part of the "biotechnology" industry.

SkinBioTherapeutics vs.

SkinBioTherapeutics (LON:SBTX) and Arix Bioscience (LON:ARIX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Arix Bioscience has higher revenue and earnings than SkinBioTherapeutics. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than Arix Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SkinBioTherapeutics£1.56M34.21-£3.71M-£1.63-14.38
Arix Bioscience£14.16M0.00£14.96M£0.11N/A

SkinBioTherapeutics has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. Comparatively, Arix Bioscience has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.

Arix Bioscience received 35 more outperform votes than SkinBioTherapeutics when rated by MarketBeat users. Likewise, 63.57% of users gave Arix Bioscience an outperform vote while only 60.26% of users gave SkinBioTherapeutics an outperform vote.

CompanyUnderperformOutperform
SkinBioTherapeuticsOutperform Votes
47
60.26%
Underperform Votes
31
39.74%
Arix BioscienceOutperform Votes
82
63.57%
Underperform Votes
47
36.43%

Arix Bioscience has a net margin of 105.64% compared to SkinBioTherapeutics' net margin of -237.95%. Arix Bioscience's return on equity of 6.41% beat SkinBioTherapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
SkinBioTherapeutics-237.95% -115.86% -61.18%
Arix Bioscience 105.64%6.41%2.18%

16.6% of SkinBioTherapeutics shares are held by institutional investors. Comparatively, 41.3% of Arix Bioscience shares are held by institutional investors. 20.4% of SkinBioTherapeutics shares are held by company insiders. Comparatively, 20.7% of Arix Bioscience shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, SkinBioTherapeutics' average media sentiment score of 0.75 beat Arix Bioscience's score of 0.00 indicating that SkinBioTherapeutics is being referred to more favorably in the media.

Company Overall Sentiment
SkinBioTherapeutics Positive
Arix Bioscience Neutral

Summary

Arix Bioscience beats SkinBioTherapeutics on 11 of the 13 factors compared between the two stocks.

Get SkinBioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBTX vs. The Competition

MetricSkinBioTherapeuticsBiotechnology IndustryMedical SectorLON Exchange
Market Cap£53.40M£124.50M£5.53B£2.56B
Dividend YieldN/A3.69%5.11%4.97%
P/E Ratio-14.383.2022.51132.50
Price / Sales34.214,249.09397.62227,865.53
Price / Cash9.0013.0238.1828.11
Price / Book13.9233.706.734.54
Net Income-£3.71M-£90.45M£3.22B£5.84B
7 Day Performance-10.44%1.76%1.38%2.70%
1 Month Performance-6.50%5.04%2.79%9.91%
1 Year Performance152.70%92.29%15.41%114.85%

SkinBioTherapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBTX
SkinBioTherapeutics
N/AGBX 22.50
-3.2%
N/A+152.7%£51.40M£1.56M-13.8411
ARIX
Arix Bioscience
N/AN/AN/AN/A£183.73M£14.16M1,290.919News Coverage
4BB
4basebio
2.1953 of 5 stars
GBX 1,122.40
-0.2%
GBX 1,600
+42.6%
+6.4%£143.78M£311,000.00-1,438.97101
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
BVXP
Bioventix
N/AGBX 2,700
+5.9%
N/A-37.6%£141.38M£13.65M17.4612Positive News
High Trading Volume
HVO
hVIVO
N/AGBX 18.50
-3.1%
N/A-33.5%£130.90M£68.74M7.63N/A
AVCT
Avacta Group
N/AGBX 33.17
-0.2%
N/A-29.0%£126.03M£26.29M-4.27120
TILS
Tiziana Life Sciences
N/AN/AN/AN/A£113.85M£-3,595,000.00-3.5911
VSN
Verseon
N/AN/AN/AN/A£112.24MN/A-5.17N/AGap Up
SCLP
Scancell
N/AGBX 10.50
-2.3%
N/A+12.5%£108.75MN/A-16.1051Gap Down
MPH
Mereo BioPharma Group plc (MPH.L)
N/AN/AN/AN/A£89.76MN/A-0.2150Gap Down

Related Companies and Tools


This page (LON:SBTX) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners